This is the first study in which both germline SNV/indel pathogenic variants and CNVs in BRCA1/2 genes have been analyzed through NGS, Sanger sequencing, and MLPA technologies in Tanzanian women with BC. This evidence concerns the gene BRCA1 and breast cancer.